Company profile
Accendra Health, Inc.
NYSE: ACH · Healthcare · Medical - Distribution
#92 of 1,422 Healthcare companies by revenuebottom-quartile growth
EA Score
62CFH 58DQ 77GM 31SS 85
v0.1 · 65/100 weight · provisional
↑ listing tenure, workforce scale · ↓ revenue growth (YoY), 3-yr revenue growth
Methodology →Revenue TTM
$2.7B
Rev growth YoY (TTM)
-59.3%
Net income (FY)
-$1.1B
Employees
6,500
as of 2026-08-13
Market cap
$92.7M
as of 2026-08-13
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$2.8B$2.8B2025
Net income-$1.1B-$1.1B2025
Operating income$27.5M$27.5M2025
Total assets$2.5B$2.5B2025
Liabilities$2.9B$2.9B2025
Equity-$461.0M-$461.0M2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Diabetes Product57%
Product and Service, Other21%
Wound Care14%
Urology8%
By geography
Not disclosed.
The read
What is Accendra Health, Inc.’s revenue?
Accendra Health, Inc. booked $2.8B in FY2025 revenue, contracting 74% year over year — slower than 87% of Healthcare companies we track, at a -39.8% net margin.
Peers · Healthcare
Neurocrine Biosciences, Inc.88ARevvity, Inc.79B+ModivCare Inc.——AMN Healthcare Services, Inc.70BQuidelOrtho Corporation54DFortrea Holdings Inc.50DNeighbors
Henrico →Key facts
CEOEdward A. Pesicka
SectorHealthcare
IndustryMedical - Distribution
HeadquartersGlen Allen, VA
ExchangeNYSE: ACH
Employees6,500
IPO date1980-03-17
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.